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higher	 spontaneous	 abortion	 rates	 (12.1%	 vs.	 17.2%,	 p  =  0.02)	 while	 induced	
abortion	and	live	birth	rates	did	not	change	significantly.	Spontaneous	abortions	
were	more	common	in	older	women	[adjusted	odds	ratio	(aOR)	=	1.4,	95%	CI:	
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INTRODUCTION
The	 2008	 ‘Swiss	 statement’	 was	 an	 important	 milestone	
proclaiming	the	safety	of	condomless	sex	in	HIV	serodis-
cordant	 couples,	 if	 the	 HIV-	infected	 partner	 was	 virally	
suppressed	 while	 taking	 combined	 antiretroviral	 therapy	





















Hence,	 birth	 control	 has	 become	 an	 important	 topic	
in	providing	care	for	WLWH.	It	is	of	great	importance	to	
avoid	unplanned	pregnancies	in	WLWH,	as	they	are	often	
associated	 with	 adverse	 outcomes	 such	 as	 unsafe	 abor-
tions,	 pregnancy	 complications	 (e.g.	 pregnancy-	related	
sepsis),	mother-	to-	child	transmission	of	HIV	and	mortal-
ity	due	to	non-	pregnancy-	related	infections	[8,9].
Currently	 it	 is	unclear	 if	 the	high	rate	of	unintended	
pregnancies	 in	 the	 SHCS	 has	 changed	 over	 time,	 and	
whether	it	was	influenced	by	the	reduced	condom	use	fol-
lowing	the	publication	of	the	Swiss	statement	in	2008.
We	 therefore	 aimed	 to	 provide	 a	 detailed	 analysis	 of	
obstetric	 events	 in	 the	 SHCS.	 In	 the	 first	 instance,	 we	








Swiss HIV Cohort Study (SHCS)
The	SHCS	(www.shcs.ch)	is	a	prospective	cohort	study	with	
ongoing	enrolment	of	HIV-	positive	adults	in	Switzerland.	
It	 has	 remained	 representative	 of	 the	 HIV	 patient	 popu-
lation	since	its	inception	in	1988,	and	currently	covers	at	
least	75%	of	all	patients	receiving	cART	and	69%	of	patients	
living	 with	 AIDS	 in	 Switzerland	 [10].	 Around	 25%	 of	 all	
SHCS	 participants	 are	 female.	 Detailed	 information	 on	
demographics,	 mode	 of	 HIV	 acquisition,	 risk	 behaviour,	












Conclusions: The	 publication	 of	 the	 Swiss	 statement	 resulted	 in	 more	 con-
domless	 sex	 in	 heterosexual	 women,	 but	 this	 did	 not	 result	 in	 a	 higher	 inci-
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2005	 (start	 of	 obstetric	 event	 information	 collection)	 and	
December	2019.	In	the	second	part,	we	assessed	the	impact	














completed,	 ‘medium’	 if	 an	 apprenticeship	 or	 bachelor	
degree	 was	 completed,	 or	 ‘high’	 if	 a	 higher	 professional	
qualification	 or	 university	 qualification	 was	 completed.	









transcriptase	 inhibitor-	based	 (NNRTI),	 each	 combined	
with	one	or	two	nucleoside	reverse	transcriptase	inhibitors	
(NRTIs)	and	as	second-	line	 treatment	 (if	 they	contained	
more	than	one	INSTI,	PI	or	NNRTI	other	than	ritonavir).
Clinical	and	behavioural	characteristics	were	recorded	
at	 the	 first	 study	 visit	 after	 an	 obstetric	 event,	 therefore	
reflecting	the	last	6 months	before	the	study	visit.
Statistical analyses
We	first	described	 the	 total	number	and	 rates	of	obstetric	




1	 and	 phase	 2.	 Group	 comparisons	 of	 categorical	 vari-


































Obstetric events in correlation to age and 
condom use over time
During	the	study	period	(July	2005–	December	2019)	3023	
women	 of	 childbearing	 age	 were	 followed	 in	 the	 SHCS.	
After	an	initial	increase	until	2008	we	observed	a	decline	
in	 the	 total	 number	 of	 women	 of	 childbearing	 age	 from	
1831	 in	 2008	 to	 994	 in	 2019,	 as	 well	 as	 declining	 total	
numbers	of	obstetric	events	from	111	in	2005	to	40	in	2019	
(Figure 1).	For	 those	 self-	declaring	 that	 they	were	 sexu-





(p  =  0.004)	 the	 absolute	 number	 was	 small	 (Figure  2).	
Pregnancy	incidence	decreased	slightly	from	6.5	(95%	CI:	
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5.4–	7.9)	 to	 5.4	 (4.0–	7.0)	 per	 100	 women-	years	 (p  =  0.2)	
(Figure	S1(A)).	We	found	that	although	the	proportion	of	
women	over	35 years	increased	over	time,	their	pregnancy	
incidence	 remained	 stable	 (Figure	 S1(B),	 top	 panel).	
By	 contrast,	 in	 the	 decreasing	 group	 of	 women	 younger	
than	35 years,	unadjusted	pregnancy	incidence	has	been	
steadily	declining	over	time	from	18.4	(95%	CI:	14.4–	23.3)	
per	 100	 women-	years	 in	 2010	 to	 11.2	 (6.7–	17.4)	 per	 100	
women-	years	in	2019	(p = 0.03).
Comparison of demographic 
characteristics and obstetric events in the 
pre- Swiss statement and post- Swiss 
statement periods
We	 evaluated	 data	 from	 2125	 women	 in	 phase	 1	 (July	
2005–	December	 2008)	 and	 2593	 women	 in	 phase	 2	
(January	 2009–	December	 2019).	 Women	 in	 phase	
1	 were	 younger	 [median	 age	 40  years,	 interquartile	
range	(IQR):	35–	44	vs.	42 years,	IQR:	37–	45,	p < 0.001],	
and	 they	were	 less	 likely	 to	be	black	 (29.1%	vs.	38.3%,	
p  <  0.001).	 In	 both	 phases	 the	 majority	 of	 women	 ac-




2	 (Table  1).	 Information	 on	 the	 use	 of	 oral	 hormonal	





ing	 time	periods	before	and	after	 the	Swiss	 statement,	
the	 live	 birth	 rate	 remained	 stable	 (67.4%	 vs.	 66.3%,	
p = 0.7),	induced	abortions	slightly	decreased	(20.5%	vs.	
F I G U R E  1  Absolute	numbers	of	women	of	childbearing	age	and	occurrence	of	obstetric	events	in	the	Swiss	HIV	Cohort	Study	over	time	
(2005–	2019)
F I G U R E  2  Sexually	active	women	of	childbearing	age	having	condomless	sex	and	obstetric	event	rates	over	time	in	the	Swiss	HIV	
Cohort	Study	(2005–	2019)
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16.4%,	 p  =  0.07)	 and	 spontaneous	 abortions	 increased	
(12.1%	vs.	17.2%)	(p = 0.02)	(Table 1).
Factors associated with 
pregnancy outcomes
During	the	study	period,	1479	pregnancies	were	reported:	
986	 (66.7%)	 of	 the	 pregnancies	 ended	 in	 live	 births,	 231	




















second-	line	 treatment),	 time	 on	 ART	 and	 psychiatric	
T A B L E  1 	 Comparison	of	demographic	characteristics	and	obstetric	events	in	women	of	childbearing	age	between	July	2005–	December	
2008	(phase	1)	and	January	2009–	December	2019	(phase	2)
Phase 1a 
[n (%) unless noted 
otherwise]
Phase 2a 
[n (%) unless noted otherwise] p- value
Women	of	childbearing	age 2125	(100) 2593	(100)












Women	with	a	stable	partner 1588	(75) 2129	(82) < 0.001
Women	having	sex	with	stable	partner 1483	(70) 1990	(77) < 0.001
Condomless	sex	with	a	stable	partner 613	(29) 1427	(55) < 0.001
Women	having	sex	with	a	casual	partner 385	(18) 542	(21) < 0.001
Condomless	sex	with	a	casual	partner 79	(4) 213	(8) < 0.001
Oral	hormonal	contraception n.a. 926	(35.7) NA
Depression n.a. 907	(35) NA
Women	who	became	pregnant 460	(100) 1003	(100)
Pregnancy	outcome
Live	birth 312	(67) 664	(66) 0.7
Spontaneous	abortion 56	(12) 175	(17) 0.02
Induced	abortion 95	(20) 167	(17) 0.07
Age	at	time	of	pregnancy	[median	(IQR)] 31	(27–	36) 34	(30–	38) < 0.001
Abbreviations:	n,	number;	IQR,	interquartile	range;	na.,	not	assessed.
aPhase	1,	July	2005–	December	2008;	phase	2,	January	2009–	December	2019.




The	 proportion	 of	 women	 of	 childbearing	 age	 in	 the	
SHCS	is	steadily	decreasing	over	time,	and	despite	more	




but	 remained	high	and	 twice	 the	 rate	 reported	 for	HIV-	
negative	 women	 by	 the	 Swiss	 authorities	 [12].	 Women	
with	HIV	viral	suppression	and	alcohol	abstinence	were	
more	likely	to	have	a	live	birth.






[n = 262 (18%)] p- value
Age	(years)	[median	(IQR)] 33	(29–	37) 35	(31–	39) 32	(27–	37) < 0.001
Risk	group	[n	(%)] 0.2
Sexual	intercourse 852	(86) 188	(81) 213	(81)
Intravenous	drug	use 50	(5) 14	(6) 15	(6)
Perinatal	infection 24	(2) 6	(3) 13	(5)
Other 60	(6) 23	(10) 21	(8)
Ethnicity 0.2
White 306	(31) 84	(36) 70	(27)
Black 601	(61) 126	(55) 171	(65)
Other 79	(8) 21	(9) 21	(8)
Stable	partnership 881	(89) 212	(92) 209	(80) < 0.001
None	or	lower	education 426	(43) 85	(37) 124	(47) 0.1
Suppressed	viral	load 910	(92) 191	(83) 185	(71) < 0.001
CD4	count	(CD4/µl)	[median	
(IQR)]
517	(378–	685) 596	(396–	765) 536	(348–	739) 0.01
Time	on	ART	(years) 3.9	(0.5–	7.8) 5.7	(1.7–	9.1) 3.7	(0.7–	8.0) 0.01
Alcohol	consumption 139	(14) 73	(32) 71	(27) < 0.001
Depression 33	(3) 17	(7) 24	(9) < 0.001
Abbreviations:	ART,	antiretroviral	therapy;	IQR,	interquartile	range;	n,	number.
T A B L E  3 	 Univariate	and	multivariate	logistic	regression	of	factors	influencing	pregnancy	continuation
Live birth versus spontaneous abortion Live birth versus induced abortion
Univariate 
LR (95% CI) p- value
Multivariate 
LR (95% CI) p- value
Univariate 
LR (95% CI) p- value
Multivariate 
LR (95% CI) p- value
Age	at	obstetric	event	
(every	5 years)
1.4	(1.2–	1.6) < 0.001 1.4	(1.2–	1.7) < 0.001 ns
Stable	sex	partner 4.6	(1.6–	12.7) 0.004 3.9	(1.5–	10.2) 0.007 3.0	(1.3–	6.8) 0.01 ns
Suppressed	HIV	load 0.4	(0.3–	0.6) < 0.001 0.2	(0.1–	0.4) < 0.001 0.2	(0.1–	0.3) < 0.001 0.3	(0.2–	0.7) 0.003
CD4	count	(100 steps) 1.1	(1.0–	1.2) < 0.001 1.1	(1.1–	1.2) < 0.001 ns
NNRTI-	based	ART 1.8	(1.3–	2.6) 0.002 1.7	(1.1–	2.5) 0.01 2.3	(1.6–	3.3) < 0.001 ns
PI-	based	ART 0.5	(0.4–	0.7) < 0.001 ns 0.3	(0.2–	0.3) < 0.001 0.3	(0.2–	0.5) < 0.001
Alcohol	consumption 2.8	(2.0–	4.0) < 0.001 2.8	(1.9–	4.1) < 0.001 2.3	(1.6–	3.2) < 0.001 1.6	(1.0–	2.4) 0.04




   | 7HIV MEDICINE
Ageing as a driver of pregnancy rates 
but not condoms use
The	 opportunity	 for	 serodiscordant	 couples	 to	 conceive	
through	 unprotected	 intercourse,	 instead	 of	 assisted	 re-
production,	 and	 increasing	 rates	 of	 condomless	 sex	 in	
the	 SHCS	 did	 not	 result	 in	 increased	 incidence	 of	 preg-
nancy	 over	 time.	 However,	 during	 the	 same	 period,	 the	
live	birth	rates	of	all	women	of	childbearing	age	living	in	
Switzerland	 decreased	 slightly	 from	 4.5	 per	 100	 person-	
years	in	2009	to	4.8	per	100	person-	years	in	2019	[13].
With	 the	 introduction	 of	 cART,	 WLWH	 have	 experi-
enced	improved	health,	longer	life	expectancy	and	fewer	
mother-	to-	child	 (vertical)	 HIV	 transmissions,	 with	 cor-
respondingly	 increasing	 live	 birth	 rates	 [14].	 Yet,	 two	
decades	after	 the	 introduction	of	 cART,	pregnancy	 rates	
of	WLWH	in	Switzerland	are	 still	 low.	Our	observations	
are	shared	by	HIV	cohorts	from	low-	and	middle-	income	
countries	 [15–	17],	 but	 data	 from	 high-	income	 countries	
are	 scarce.	 Nonetheless,	 our	 findings	 are	 in	 line	 with	

















The	 declining	 pregnancy	 incidence	 in	 our	 study	 is	
instead	 driven	 by	 two	 different	 developments:	 a	 higher	












an	 important	 issue	 in	 HIV-	positive	 women.	 Iyer	 at	 al.	
[15]	reported	subfertility	in	two	out	of	three	HIV-	positive	
couples	 in	 South	 Africa	 and	 elevated	 risk	 of	 infertility	
compared	with	HIV-	negative	women	even	when	on	cART.	
Data	on	 the	effects	of	ART	on	reproduction	have	postu-
















Why do abortions not decrease?
Despite	having	over	90%	of	women	on	cART	and	virally	
suppressed,	 only	 two	 in	 three	 pregnancies	 of	 WLWH	 in	
Switzerland	ended	in	a	live	birth.
EuroSIDA	 recently	 reported	 similar	 pregnancy	 out-
comes	 from	 women	 across	 Europe,	 Argentina	 and	 Israel	




spontaneous	 abortion	 has	 been	 frequently	 reported	 from	
high-	 and	 low-	income	 settings	 [25–	27].	 However,	 studies	








no	 significant	 trends	 over	 the	 years	 when	 age-	adjusted,	
and	showed	that	if	on	cART	and	properly	matched,	HIV-	
positive	 and	 -	negative	 women	 do	 not	 differ	 in	 terms	 of	





determining	 factor	 for	 the	 increased	 rate	 of	 spontaneous	
abortions.	In	our	study,	the	increasing	maternal	age	seems	
most	 likely	 to	be	responsible	 for	miscarriages,	due	 to	 the	




a	 lesser	 extent	 than	 in	 HIV-	positive	 women:	 notably	 the	
median	age	at	birth	in	2019	was	32 years	in	HIV-	negative	
versus	37 years	in	the	SHCS	[29].
In	 the	 years	 following	 the	 introduction	 of	 cART,	 a	
worldwide	 decrease	 of	 induced	 abortions	 was	 observed.	
Over	the	last	decade	the	rates	of	induced	abortions	do	not	
seem	to	have	decreased	further	in	contrast	to	the	steadily	


































been	 reported	 in	 other	 studies	 [38].	 One	 of	 the	 reasons	
might	be	fear	of	potential	drug–	drug	interactions	(DDIs),	
which	 prevents	 doctors	 from	 prescribing	 hormonal	 con-
traceptives.	 With	 the	 available	 data,	 we	 are	 not	 able	 to	





































In	 order	 to	 meet	 the	 reproductive	 health	 needs	 of	
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-	 Decreasing	 condom	 use	 and	 its	 impact	 on	 obstetric	
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-	 Live	births,	spontaneous	and	induced	abortions	in	the	
Swiss	 HIV	 Cohort	 Study	 (SHCS):	 Which	 factors	 may	
predict	 pregnancy	 outcomes?	 Poster	 presentation	 at	
HIV	Drug	Therapy	2018,	Glasgow,	UK
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